COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.41 -0.78 (-6.36%)

Delayed Quote Updated: 3:18 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

33 34 Next >

Psychedelic Stock Gainers And Losers From February 21, 2023 ↗

February 21, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From February 20, 2023 ↗

February 20, 2023

Via Benzinga

John Oliver's Take On Psychedelic Assisted Therapy: There's Huge Potential If Done Responsibly ↗

February 20, 2023

John Oliver is back on "Last Week Tonight" and is once again taking a deep dive into a very intriguing topic: the potential benefits of psychedelic-assisted therapy. The show, which aired on Sunday,...

Via Benzinga

"Rags-To-Riches" Portfolio Underperforming YTD ↗

February 19, 2023

The munKNEE

Via Talk Markets

6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD ↗

February 17, 2023

A look at the performance of the six largest psychedelic stocks by market capitalization.

Via Talk Markets

ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today ↗

February 17, 2023

Via Benzinga

Cybin, Compass Pathways Among Top Psychedelic Movers Of Today ↗

February 16, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From February 15, 2023 ↗

February 15, 2023

Via Benzinga

GH Research, Mind Medicine Among Top Psychedelic Movers Of Today ↗

February 14, 2023

Via Benzinga

Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗

February 13, 2023

Via Benzinga

10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More ↗

February 13, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

7 Long-Term Stocks to Buy With Your Tax Refund ↗

February 12, 2023

Although you might want to spend your tax refund, a better approach is to target compelling long-term stocks to buy.

Via InvestorPlace

Major Psychedelic Compound-Based Stocks UP 13% YTD ↗

February 11, 2023

We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances.

Via Talk Markets

Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

February 10, 2023

Via Benzinga

Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

February 09, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From February 8, 2023 ↗

February 08, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From February 7, 2023 ↗

February 07, 2023

Via Benzinga

3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street ↗

February 07, 2023

These stocks are risky. But they just might deliver huge gains if analysts are right.

Via The Motley Fool

7 Tempting Sin Stocks to Buy for Promising Profits ↗

February 06, 2023

After a rough time in 2022, investors may want to consider sin stocks to buy for a cynical shot at significant upside potential.

Via InvestorPlace

Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗

February 06, 2023

Via Benzinga

EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions ↗

February 06, 2023

(Part one of a three-part series)

Via Benzinga

The 7 Most Promising Psychedelic Stocks to Buy in February ↗

February 05, 2023

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

Via InvestorPlace

6 Largest Psychedelic Stocks Down 3% This Week ↗

February 04, 2023

The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss...

Via Talk Markets

Psychedelic Stock Gainers And Losers From February 3, 2023 ↗

February 03, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From February 2, 2023 ↗

February 02, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From February 1, 2023 ↗

February 01, 2023

Via Benzinga

GH Research, Mind Medicine Among Top Psychedelic Movers Of Today ↗

January 31, 2023

Via Benzinga

Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗

January 30, 2023

Via Benzinga

The "Rags-To-Riches" Portfolio Update: Week Ending January 27 ↗

January 29, 2023

The Rags-to-Riches Portfolio tracks the performance of 14 cannabis, psychedelic and plant-based food stocks constituent . Here, performances last week and year-to-date.

Via Talk Markets

Top 3 Psychedelic Storylines To Watch In 2023 ↗

January 29, 2023

This article by James Hallifax was originally published on Microdose and appears here with permission.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.